N/A N=53 Motivating a Spectrum of Cancer Patients to Quit Smoking
Cancer · Smoking
Primary: Number of Participants Who Consent to Participate in the Study- Feasibility — 53 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=42 Investigating the Experience of Living With Down Syndrome and Obstructive Sleep Apnea Syndrome (Stage 1)
Down Syndrome · Obstructive Sleep Apnea
Primary: Number of Participants Who Completed Interviews Regarding Positive Airway Pressure (PAP) Acceptability — 20; 21 Participants
N/A N=150 Methods Project 4: Clinical Trial
Smoker
Primary: Smoke-free Days — 14.5; 0; 0 days
N/A N=65 PREVENT Tool Study: Late Effects Clinic
Cardiovascular Disease · Childhood Obesity
Primary: Mean Change in Minutes of Moderate Physical Activity Per Week (From Self Report) Survey — 43.3; 16.8 minutes/week
Phase 2 N=8 Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor AZD1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery
Metastatic Pancreatic Adenocarcinoma · Stage III Pancreatic Cancer AJCC v6 and v7 · Stage IV Pancreatic Cancer AJCC v6 and v7
Primary: Number of Participants With Dose Limiting Toxicities (DLT) — 2; 2 Participants
N/A N=102 Suppression of HIV 1 RNA in People Living With HIV
HIV
Primary: Undetectable Viral Loads During Treatment — 70.4; 42.5 percentage of blood samples undetectable — p=<0.001
N/A N=100 Translational Model of Anhedonia
Anhedonia
Primary: Reward Positivity Component of the Event-Related Electroencephalogram — 7.29; 9.23 Microvolts — p=.071
N/A N=60 Adjunct VR Pain Management in Acute Brain Injury
Traumatic Brain Injury · Headaches Posttraumatic · Trauma
Primary: Change in Pain Score — -0.92; -0.16; -1.24 score on a scale
N/A N=128 Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients
Sars-CoV2 · Covid-19
Primary: Proportion of Smartphone Based Surveys Completed — 0.46; 0.44 proportion of daily surveys completed
N/A N=73 Association of Type of Anesthetic and Outcomes in Transfemoral Aortic Valve Replacement
Aortic Stenosis
Primary: Procedure Length — 114.5; 100 minutes
N/A N=37 Giving Information Systematically and Transparently in Lung and GI Cancer Phase 2
Critical Illness · Oncology · Communication
Primary: Change in Prognostic Understanding — 0.58; 0.18 units on a scale
Phase 2 N=233 The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression
Treatment Resistant Depression
Primary: Montgomery Asberg Depression Rating Scale (MADRS) Change From Baseline to Week 3 — -12; -8.9; -6.8 units on a scale — p=<0.05
Phase 4 N=114 The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance
Ptosis, Eyelid · Conjunctiva Inflamed · Eye Manifestations
Primary: Change in Palpebral Fissure Height — 1.1; -0.4 mm
Phase 4 N=210 Effect of IV Acetaminophen on Patients in the Neurocritical Care Unit
Post-operative Craniotomy Patients · Carotid Endarterectomy and Carotid Artery Stenosis Patients · Post-op Spine Patients Admitted to the NCCU
Primary: Narcotic Requirement After Surgery — 123.5; 134.2 Morphine Equivalents
N/A N=9 Chronic Effects of DBS in Parkinson's Disease and Dystonia
Parkinson's Disease · Isolated Dystonia
Primary: Number of Patients With Parkinson's Disease With Reliable Cortical and Sub-cortical Brain Signals — 5 Participants